SHINE Secures European Marketing Authorization for Ilumira, Latest Step in Building Integrated Nuclear Medicine Platform May 29, 2026 Read more
Press Release: SHINE and C-Ray Therapeutics Establish Strategic Partnership for Exclusive Distribution of Non-Carrier-Added Lu-177 in Mainland China Mar 26, 2026 Read more